Back to Journals » Cancer Management and Research » Self Screening for Cancer: Promises and Pitfalls
Cancer Management and Research
- View all (5177)
- Volume 18, 2026 (143)
- Volume 17, 2025 (276)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Journal Articles:
- Self Screening for Cancer: Promises and Pitfalls (1)
- Immune Effector Cells for Cancer Therapy – CAR-T and beyond (1)
- Defining Genetic Contributors to Cancer Risk (1)
- The Cancer Treatment Revolution and the Threat to Equitable Global Medicines Access (2)
- Establishing New Standards in Neuroendocrine Tumors: Raising the Bar to Set New Benchmarks (1)
Self Screening for Cancer: Promises and Pitfalls
Cancer is a leading cause of death worldwide, and early detection can significantly improve prognosis. However, many individuals are not screened or are inadequately screened for cancer. Self-screening for cancer has the potential to lead to earlier detection, which in turn enables earlier treatment and better survival rates. It has also been touted as a way to reduce disparities in cancer outcomes, as self-screening kits could be made available to individuals without access to high-quality in-office screening.
Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer
Mkuu RS, Tohme S, Rivero-Mendoza D, Salloum RG, Goede D, Bruggeman B, Nicholson K, Hall JM, Bylund C, Woodard JN, Hensley J, Shenkman EA, Donahoo WT, Mulugeta A, Hernandez M, Staras SA
Cancer Management and Research 2025, 17:3273-3284
Published Date: 24 December 2025